Apomorphine (administration & dosage) < Apomorphine (adverse effects) < Apomorphine (blood)

Facettes :

List of bibliographic references indexed by Apomorphine (adverse effects)

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
001805 (2011)	Jeban Ganesalingam [Royaume-Uni] ; Peter Bain [Royaume-Uni]	Apomorphine‐induced necrotic ulcers
001937 (2010)	Stephen Gancher [États-Unis] ; John Nutt [États-Unis]	Tolerance to apomorphine develops and reverses rapidly
002001 (2009)	Leon Poltawski [Royaume-Uni] ; Hazel Edwards [Royaume-Uni] ; Amy Todd [Royaume-Uni] ; Tim Watson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Cherry Ann James [Royaume-Uni]	Ultrasound treatment of cutaneous side‐effects of infused apomorphine: A randomized controlled pilot study
002416 (2009)	Frank Andersohn [Allemagne] ; Edeltraut Garbe [Allemagne]	Cardiac and noncardiac fibrotic reactions caused by ergot‐and nonergot‐derived dopamine agonists
003277 (2006)	Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Donna Pires [Canada] ; Valerie Voon [Canada, États-Unis] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]	Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
003600 (2006)	Björn Tackenberg [Allemagne] ; J. Carsten Möller [Allemagne] ; Karla Eggert [Allemagne] ; Norbert Sommer [Allemagne] ; Wolfgang H. Oertel [Allemagne]	Akinetic crisis caused by rectus sheath hematoma and acute anemia due to subcutaneous administration of apomorphine
003945 (2005)	Svenja Happe [Allemagne] ; Martin Sommer [Allemagne] ; Johannes Meller [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Walter Paulus [Allemagne]	Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder
003B37 (2004)	Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France]	Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study
004520 (2002)		DA agonists ‐ Non‐Ergot derivaties: Apomorphine
004571 (2002)	Alice J. Manson [Royaume-Uni] ; Kirsten Turner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long‐term follow‐up study of 64 patients
004958 (2000)	Stewart A. Factor [États-Unis] ; Diane L. Brown [États-Unis] ; Eric S. Molho [États-Unis]	Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease
004B41 (2000)	Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]	Apomorphine: An underutilized therapy for Parkinson's disease
004E09 (1999)	Marcelo Merello [Argentine] ; Jorge Balej [Argentine] ; Marina Delfino [Argentine] ; Angel Cammarota [Argentine] ; Osvaldo Betti [Argentine] ; Ram N Leiguarda [Argentine]	Apomorphine induces changes in GPi spontaneous outflow in patients with parkinson's disease
004E85 (1998)	van Laar ; Bob Van Hilten ; Cees Neef ; A. Wijnand F. Rutgers ; Stan Pavel ; J. Anthony Bruijn	The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: A histologic study
005069 (1998)	John D. O'Sullivan [Australie] ; Andrew J. Hughes [Australie]	Apomorphine‐induced penile erections in Parkinson's disease
005094 (1998)	Richard B. Dewey Jr [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Joseph Y. Matsumoto [États-Unis]	A double‐blind, placebo‐controlled study of intranasal apomorphine spray as a rescue agent for off‐states in Parkinson's disease
005566 (1996)	F. Stocchi [Italie] ; M. F. De Pandis [Italie] ; F. A. Delfino [Italie] ; T. Anselmo [Italie] ; D. Frongillo [Italie]	Transient atrial fibrillation after subcutaneous apomorphine bolus
005659 (1996)	Tison [France] ; L. Wiart [France] ; M. Guatterie [France] ; N. Fouillet [France] ; V. Lozano [France] ; P. Henry [France] ; M. Barat [France]	Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease
005673 (1996)	Eichhorn [Allemagne] ; T. Gasser [Allemagne] ; N. Mai [Allemagne] ; C. Marquardt [Allemagne] ; G. Arnold [Allemagne] ; J. Schwarz [Allemagne] ; W. H. Oertel [Allemagne]	Computational analysis of open loop handwriting movements in Parkinson's disease: A rapid method to detect dopamimetic effects
005847 (1995)	van Laar [Pays-Bas] ; E. N. H. Jansen ; C. Neef ; M. Danhof [Pays-Bas] ; R. A. C. Roos [Pays-Bas]	Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: A study of five different suppositories
005D26 (1993)	A. J. Hughes [Royaume-Uni] ; Susan Bishop [Royaume-Uni] ; Birgit Kleedorfer [Royaume-Uni] ; Nora Turjanski [Royaume-Uni] ; W. Fernandez [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. Stern [Royaume-Uni]	Subcutaneous apomorphine in parkinson's disease: Response to chronic administration for up to five years

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Apomorphine (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Apomorphine (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Apomorphine (adverse effects)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024